NCT00320814View on ClinicalTrials.gov

Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2007

Conditions
Diabetic Macular Edema
Interventions
DRUG

VEGF Trap-Eye

single IVT injection of 4.0 mg of VEGF Trap-Eye into the study eye on Day 1

Trial Locations (2)

21287

Baltimore

28210

Charlotte

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT00320814 - Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema | Biotech Hunter | Biotech Hunter